Illumina Announces GRAIL Spin-off as Regulatory Boot Finally Drops

IlluminaAnnounced on Sunday that it will spin off GRAIL, the divestiture will be executed through third-party sales or capital market transactions in compliance with the European Commission's divestiture order, with the goal of 2024 Finalize the terms by the end of the second quarter of the year.

This doesn't seem like news anymore.

Last week15On a certain day, the U.S. Court of Appeals for the Fifth Circuit Illumina Complaint against the Federal Trade CommissionFTCA complex ruling was made in the case. The court essentially upheldFTCThe decision, namely Illumina Should be terminated for antitrust reasons with Grail The transaction. After reviewing the court's opinion,Illumina Chooses not to appeal the Fifth Circuit Court's ruling. As the company previously stated, if neither the appeal concerning the jurisdiction of the European Court nor the final ruling of the Fifth Circuit Court succeeds, it will divest. GRAIL。

2023The biggest shoe of the year has dropped.

2021Year,IlluminaDespite opposition from antitrust enforcers,80Billion-dollar acquisition ofGrail. Investors were dissatisfied with the deal, which took place earlier this year. Illumina One of the main factors in the leadership reshuffle, including the main advocate of the deal, then-CEO Francis deSouza The downfall.

In view of the opposition from regulatory authorities,Illumina Has been preparing for the possibility of having to detach from Grail The possibility to prepare. During the emergence of legal challenges,Illumina Will Grail Business is separated from other businesses.

Earlier this summer, European regulatory authorities Illumina Being overly eager in transactions and thus Illumina Impose 4.76 Billion-dollar fines and require Grail Remain as competitive as before the acquisition under any divestiture plan.

Earlier this month,Illumina Took an official step towards asset divestiture and submitted a Form 10, allowing the company to engage with external parties interested in the transaction. Illumina Chief Financial Officer Joydeep Goswami At an investor meeting, it was stated that,Illumina Have received quite a few responses toGrail The“Interest”。

Analysts expect that the market for blood tests used to detect cancer could eventually reach 500 Billion US dollars.Grail The Galleri The development of the test (a blood test that can detect multiple types of cancer) is nothing short of a miracle. IfGrail If it can proceed smoothly, I believe there will be institutions interested in considering it.Illumina Expected Grail In 2023 The fiscal year will be achieved 9000 Million USD in revenue and 6.6 Billion-dollar operating loss.

Grail The prospect will depend on whether it is sold to a buyer or spun off as an independent company. If Illumina Escape through capital market transactions such as initial public offerings Grail, European regulatory authorities will require Illumina Providing two and a half years of financing to Grail Capitalization.

IlluminaDecision to Spin Off Grail The decision brought an end to years of pain, as the acquisition had weighed down the company's stock price.Illumina On Monday to SEC After submitting the draft of the divestiture plan, the stock price rose immediately, with an overall increase of over10%。 It is clear that major investors are eagerGrailDivestment occurred despite concerns about how the divestment would take place—particularly Illumina How to Raise the Support Required by the European CommissionGrailDevelopment20 Billion dollars in funding.

But I believe once peeled offGrail，Illumina Can focus on core gene sequencing business.

Coming Soon2024Year, worth looking forward to.